Digital health program could transform diabetes care for seniors with multiple illnesses

NCT ID NCT07310849

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 6-month digital care program for adults aged 50+ with type 2 diabetes and at least one other chronic condition like high blood pressure or kidney disease. The program combines online education, phone support, a mobile health app, home visits, and personalized care plans. Researchers will track whether it improves disease control, self-management, depression, and quality of life compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Digital Care Community Common Good program (behavioral intervention including online and in-person education, telephone care, mHealth platform, home visits, and individualized care plans)
What this could lead to
If successful, this program could provide a practical, community-based approach to improve self-management and quality of life for older adults with diabetes and multiple chronic conditions.
What could go wrong
This is a small, early-stage study (169 participants) focused on behavioral changes, not a drug or cure. Results may not apply to other populations or settings, and improvements may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIO VASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Wugu District Public Health Center,

    New Taipei City, Wugu District, 248524, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.